3-(2-aminopyridin-4-yl)-N-(1-(3-chlorophenyl)-2-hydroxyethyl)-1H-indazole-5-carboxamide

ID: ALA3797827

Chembl Id: CHEMBL3797827

PubChem CID: 127047176

Max Phase: Preclinical

Molecular Formula: C21H18ClN5O2

Molecular Weight: 407.86

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1cc(-c2n[nH]c3ccc(C(=O)NC(CO)c4cccc(Cl)c4)cc23)ccn1

Standard InChI:  InChI=1S/C21H18ClN5O2/c22-15-3-1-2-12(8-15)18(11-28)25-21(29)14-4-5-17-16(9-14)20(27-26-17)13-6-7-24-19(23)10-13/h1-10,18,28H,11H2,(H2,23,24)(H,25,29)(H,26,27)

Standard InChI Key:  DIJMZIXDGKPCOI-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3797827

    ---

Associated Targets(Human)

MAPK3 Tchem MAP kinase ERK1 (4725 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK1 Tchem MAP kinase ERK2 (25055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 407.86Molecular Weight (Monoisotopic): 407.1149AlogP: 3.32#Rotatable Bonds: 5
Polar Surface Area: 116.92Molecular Species: NEUTRALHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 13.15CX Basic pKa: 5.37CX LogP: 2.65CX LogD: 2.65
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.40Np Likeness Score: -0.91

References

1. Li L, Liu F, Jin N, Tang S, Chen Z, Yang X, Ding J, Geng M, Jiang L, Huang M, Cao J..  (2016)  Discovery and structure activity relationship study of novel indazole amide inhibitors for extracellular signal-regulated kinase1/2 (ERK1/2).,  26  (11): [PMID:27106711] [10.1016/j.bmcl.2016.04.029]

Source